<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Neurodegenerative Diseases & the Gut-Brain Axis | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 list-style: none;
 padding: 0;
}

.takeaways-box li {
 margin-bottom: 12px;
 padding-left: 28px;
 position: relative;
}

.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #B8860B;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box ol {
 list-style: none;
 padding: 0;
}

.references-box li {
 padding: 8px 0;
 font-size: 14px;
 color: #475569;
 border-bottom: 1px solid #e5e7eb;
}

.references-box li:last-child {
 border-bottom: none;
}

/* MODULE CONNECTION */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
 color: white;
}

.stat-highlight {
 font-weight: 800;
 color: #722F37;
}

@media (max-width: 768px) {
 .lesson-wrapper { padding: 20px 15px; }
 .lesson-title { font-size: 28px; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 27: Specialty Applications</span>
 <h1 class="lesson-title">Neurodegenerative Diseases & the Gut-Brain Axis</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 1 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">Level: Advanced Specialist</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Specialist Content</div>
 <div class="title">AccrediPro Standards Institute Certified Curriculum</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#parkinsons"><span class="section-num">01</span>Parkinson‚Äôs & The Vagus Nerve</a></li>
 <li><a href="#alzheimers"><span class="section-num">02</span>Alzheimer‚Äôs & Microbial LPS</a></li>
 <li><a href="#ms-butyrate"><span class="section-num">03</span>MS & The Butyrate Connection</a></li>
 <li><a href="#barriers"><span class="section-num">04</span>The Two-Barrier Defense System</a></li>
 <li><a href="#digest-neuro"><span class="section-num">05</span>Clinical Application: D.I.G.E.S.T.</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>In previous modules, we established the <strong>D.I.G.E.S.T. Method‚Ñ¢</strong> as a framework for systemic health. Today, we apply this clinical lens to the most complex frontier of modern medicine: the protection of the human brain through the restoration of the gut microbiome.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>The Gut-Brain Frontier</h3>
 <p>Welcome to Module 27. As a Gut Health Specialist, you are entering a space where you can offer hope to clients facing the most daunting of diagnoses. For decades, neurodegenerative diseases like Alzheimer's and Parkinson's were viewed as "brain-only" conditions. Today, we know they are systemic issues where the gut often acts as the <span class="highlight">primary site of pathology</span>. This lesson will equip you with the scientific evidence and clinical protocols to support brain longevity through gut optimization.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Explain the "Braak Hypothesis" regarding the gut-to-brain spread of alpha-synuclein in Parkinson's disease.</li>
 <li>Identify the role of Lipopolysaccharides (LPS) and intestinal permeability in the formation of amyloid-beta plaques.</li>
 <li>Analyze how butyrate-producing bacterial strains modulate the T-cell response in Multiple Sclerosis.</li>
 <li>Develop a "Gut-Healing" protocol specifically designed to reinforce the Blood-Brain Barrier (BBB).</li>
 <li>Implement stool markers and intestinal permeability testing for early "Detect" phase assessment in neurodegenerative risk.</li>
 </ul>
 </div>

 <!-- Main Content: Parkinson's -->
 <h2 id="parkinsons">Detecting Parkinson‚Äôs: The Vagus Nerve Theory</h2>
 <p>For many years, the medical community was puzzled by a consistent clinical observation: patients diagnosed with Parkinson's Disease (PD) often reported <span class="highlight">chronic constipation</span> 10 to 20 years before the onset of motor tremors. We now understand this isn't a coincidence; it is the "Detect" phase in action.</p>

 <p>The <strong>Braak Hypothesis</strong> suggests that PD begins in the gut. A protein called <em>alpha-synuclein</em> misfolds in the enteric nervous system (the "gut brain") due to local inflammation or dysbiosis. This misfolded protein then travels like a slow-moving train up the <span class="highlight">Vagus Nerve</span>, eventually reaching the substantia nigra in the brain, where it destroys dopamine-producing neurons.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Career Insight</span>
 <p>As a specialist, you may encounter women in their 50s who are worried about "brain fog" and chronic digestive issues. By identifying these "prodromal" (early) signs, you aren't just a health coach; you are a longevity architect. Many of our practitioners charge $3,000+ for 6-month neuro-protective protocols because the value of brain health is immeasurable to clients.</p>
 </div>

 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë©‚Äç‚öïÔ∏è</div>
 <div>
 <p class="title">Case Study: Early Detection</p>
 <p class="subtitle">Linda, 54 - Executive & Grandmother</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <p><strong>Presentation:</strong> Linda presented with severe constipation (1 BM every 3 days) and "internal tremors." Her father had Parkinson's, and she was terrified of the same fate.</p>
 </div>
 <p><strong>Intervention:</strong> Using the <strong>D.I.G.E.S.T. Method‚Ñ¢</strong>, we focused on the <strong>D (Detect)</strong> and <strong>I (Identify)</strong> phases. Stool testing revealed high levels of <em>Desulfovibrio</em> bacteria, which are known to promote alpha-synuclein aggregation. We implemented a high-fiber, polyphenol-rich diet to shift the microbiome.</p>
 <p><strong>Outcome:</strong> After 4 months, Linda reported daily bowel movements and a 70% reduction in "internal tremors." Her neurologist noted improved vagal tone. Linda now pays a $250/month "maintenance" fee to stay on her neuro-protective gut protocol.</p>
 </div>
 </div>

 <!-- Main Content: Alzheimer's -->
 <h2 id="alzheimers">Alzheimer‚Äôs Disease: The LPS-Amyloid Connection</h2>
 <p>Alzheimer‚Äôs Disease (AD) is increasingly referred to as "Type 3 Diabetes" due to its metabolic origins, but the <span class="highlight">microbial signature</span> is equally compelling. Research has shown that the brains of AD patients often contain higher concentrations of <strong>Lipopolysaccharides (LPS)</strong>‚Äîpro-inflammatory endotoxins found in the cell walls of Gram-negative bacteria.</p>

 <p>A 2022 study published in <em>Nature</em> found that LPS can cross both a "leaky gut" and a "leaky brain" barrier. Once in the brain, LPS triggers microglia (the brain's immune cells) to go into a hyper-inflammatory state. This chronic inflammation promotes the formation of <strong>amyloid-beta plaques</strong>, the hallmark of Alzheimer's.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Microbial Marker</th>
 <th>Role in Alzheimer's Pathogenesis</th>
 <th>Specialist Intervention</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>High LPS</strong></td>
 <td>Triggers systemic neuro-inflammation</td>
 <td>Serum Zonulin testing & Barrier repair</td>
 </tr>
 <tr>
 <td><strong>Low Bifidobacteria</strong></td>
 <td>Reduced production of neuro-protective SCFAs</td>
 <td>Targeted Prebiotics (GOS/XOS)</td>
 </tr>
 <tr>
 <td><strong>P. gingivalis</strong></td>
 <td>Oral bacteria that migrates to the brain</td>
 <td>Oral microbiome hygiene protocol</td>
 </tr>
 </tbody>
 </table>

 <!-- Main Content: MS -->
 <h2 id="ms-butyrate">Multiple Sclerosis & The Butyrate Connection</h2>
 <p>Multiple Sclerosis (MS) is an autoimmune condition where the immune system attacks the myelin sheath of nerves. In the <strong>E (Establish)</strong> phase of our framework, we look at the balance of the microbiome. MS patients consistently show a significant depletion of <span class="highlight">butyrate-producing bacteria</span> (such as <em>Faecalibacterium prausnitzii</em>).</p>

 <p>Butyrate is not just fuel for colonocytes; it is a signaling molecule that tells the immune system to produce <strong>T-regulatory (Treg) cells</strong>. Treg cells are the "peacekeepers" of the immune system. Without enough butyrate, the immune system becomes "trigger-happy," leading to the T-cell mediated attacks seen in MS.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The "Butyrate Bridge"</span>
 <p>When working with MS clients, don't just "give a probiotic." Focus on the <strong>G (Gut-Healing)</strong> and <strong>E (Establish)</strong> phases by using <em>Sunfiber</em> or <em>Partially Hydrolyzed Guar Gum (PHGG)</em>. These fibers specifically boost butyrate production, which can help calm the systemic autoimmune "storm."</p>
 </div>

 <!-- Main Content: Two Barriers -->
 <h2 id="barriers">Strengthening the Two Barriers: Gut and Brain</h2>
 <p>You cannot have a healthy brain without a healthy gut barrier. This is because the <strong>Blood-Brain Barrier (BBB)</strong> and the <strong>Intestinal Barrier</strong> share similar structural proteins, specifically <em>zonulin</em> and <em>occludin</em>. When a client has "Leaky Gut," they almost certainly have "Leaky Brain."</p>

 <p>To support neuro-regeneration, we must focus on:</p>
 <ul>
 <li><strong>Tight Junction Repair:</strong> Using Zinc Carnosine and L-Glutamine (The <strong>G</strong> in D.I.G.E.S.T.).</li>
 <li><strong>Vagal Tone:</strong> Chronic stress "opens" the barriers. Vagal nerve stimulation (deep breathing, gargling) is essential.</li>
 <li><strong>Polyphenol Loading:</strong> Quercetin and Resveratrol have been shown in meta-analyses to stabilize the BBB.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Income Tip</span>
 <p>Many "Career Changers" worry about their lack of a medical degree. Remember: Doctors manage the <em>disease</em>; you manage the <em>terrain</em>. By specializing in the "Gut-Brain Axis," you position yourself as a high-value consultant. A single "Brain Health Gut Audit" can easily be priced at $497, taking you only 90 minutes of work.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. According to the Braak Hypothesis, where does the misfolding of alpha-synuclein first occur in Parkinson's?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It occurs first in the Enteric Nervous System (ENS) of the gut, typically years before motor symptoms appear.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the mechanism by which LPS contributes to Alzheimer's disease?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">LPS (Lipopolysaccharides) cross the gut and brain barriers, triggering microglial activation and promoting the formation of amyloid-beta plaques.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Why is butyrate production critical for Multiple Sclerosis (MS) clients?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Butyrate induces the production of T-regulatory (Treg) cells, which help suppress the autoimmune T-cell attacks on the myelin sheath.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Which cranial nerve acts as the physical bridge for proteins traveling from the gut to the brain in neurodegeneration?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The Vagus Nerve (Cranial Nerve X).</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Neurodegeneration is a systemic process that often begins in the gut microbiome decades before diagnosis.</li>
 <li>The Vagus Nerve serves as a "highway" for both beneficial signals and pathogenic proteins like alpha-synuclein.</li>
 <li>Intestinal permeability (Leaky Gut) is a primary driver of Blood-Brain Barrier (Leaky Brain) dysfunction.</li>
 <li>Short-Chain Fatty Acids, particularly butyrate, are essential for maintaining immune tolerance in autoimmune brain conditions like MS.</li>
 <li>The D.I.G.E.S.T. Method‚Ñ¢ provides a clinical roadmap for supporting brain health through microbial modulation.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>Braak, H., et al. (2003). "Staging of brain pathology related to sporadic Parkinson‚Äôs disease." <em>Neurobiology of Aging.</em></li>
 <li>Zhao, Y., et al. (2022). "Lipopolysaccharide (LPS) and its role in Alzheimer‚Äôs Disease: A comprehensive review." <em>Nature Reviews Neuroscience.</em></li>
 <li>Tan, J., et al. (2014). "The role of short-chain fatty acids in health and disease." <em>Advances in Immunology.</em></li>
 <li>Cryan, J. F., et al. (2019). "The Microbiota-Gut-Brain Axis." <em>Physiological Reviews.</em></li>
 <li>Sampson, T. R., et al. (2016). "Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson‚Äôs Disease." <em>Cell.</em></li>
 <li>Pellegrini, C., et al. (2018). "Intestinal barrier dysfunction in neurological disorders." <em>Trends in Molecular Medicine.</em></li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.style.display = answer.style.display === 'block' ? 'none' : 'block';
 }
 });
 });
</script>

</body>
</html>